Complete Filing Data
Aptorum Group Ltd reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $13.74 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Aptorum Group Ltd did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.4M | -$4.3M | -$2.8M | -$9.8M | -$25.0M | $4.9M | -$20.1M | -$14.8M |
| Research And Development Expense | $352.9K | $2.2M | $5.2M | $9.2M | $10.9M | $11.6M | $6.9M | $3.1M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$181.5K | $99.8K | -$44.4K | $35.8K | -$55.3K | $58.8K | -$10.9K | -$1.1M |
| Nonoperating Income Expense | $441.1K | -$217.2K | $6.4M | $6.0M | -$7.9M | $25.2M | -$1.9M | -$4.8M |
| Interest Income Expense Nonoperating Net | -$95.7K | -$146.9K | -$121.1K | $146.6K | -$93.6K | -$243.6K | -$3.7M | -$4.5M |
| General And Administrative Expense | $573.1K | $669.5K | $1.9M | $5.2M | $5.4M | $4.9M | $7.4M | $4.9M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$1.6M | -$4.1M | -$4.4M | -$9.8M | -$27.2M | $5.0M | -$20.1M | -$16.3M |
| Comprehensive Income Net Of Tax | -$1.5M | -$4.2M | -$2.9M | -$11.5M | -$25.1M | $6.4M | -$18.7M | -$15.9M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$181.5K | $99.8K | -$44.4K | $35.8K | -$55.3K | $58.8K | -$10.9K | $5.3K |
| Net Income Loss Attributable To Noncontrolling Interest | -$13.2K | $110.1K | -$1.5M | -$1.7M | -$2.1M | $2.1M | $1.4M | $302.8K |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$110.1K | $1.5M | $1.7M | -$2.1M | -$2.1M | -$1.4M | -$302.8K | |
| Interest Expense And Accretion Of Convertible Debts | $180.0K | $180.0K | $45.3K | $87.5K | $130.4K | $237.2K | $3.8M | $4.6M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$181.5K | $99.8K | -$44.4K | $35.8K | ||||
| Operating Expenses | $18.8M | $20.7M | $21.2M | $18.7M | $10.7M | |||
| Cost Of Healthcare Service | $1.2M | $1.5M | $1.0M | $794.5K | $318.0K | |||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest | -$13.2K | $110.1K | -$1.5M | |||||
| Revenues | $431.4K | $1.3M | $1.5M | |||||
| Cost Of Revenue | $420.8K | $1.2M | $1.5M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $23.1M | $21.1M | $24.8M | $15.7M | $23.6M | $41.8M | $16.4M | $33.1M | $30.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.5M | $874.2K | $2.0M | $5.0M | $8.3M | $3.6M | $5.3M | $26.1M | $16.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$3.2M | $4.6M | -$1.7M | -$20.8M | $9.4M | ||||
| Retained Earnings Accumulated Deficit | -$73.8M | -$72.4M | -$68.2M | -$65.3M | -$55.5M | -$30.5M | -$37.6M | -$17.4M | -$2.5M |
| Minority Interest | -$9.4M | -$9.4M | -$9.5M | -$7.9M | -$6.1M | -$3.7M | -$1.5M | -$368.5K | -$14.0K |
| Liabilities Current | $4.6M | $4.3M | $2.1M | $12.5M | $4.4M | $3.9M | $2.7M | $12.2M | $1.3M |
| Liabilities And Stockholders Equity | $18.7M | $16.1M | $20.6M | $20.9M | $21.9M | $44.2M | $24.0M | $45.1M | $31.6M |
| Liabilities | $4.9M | $4.4M | $5.3M | $13.0M | $4.4M | $6.1M | $9.1M | $12.3M | $1.3M |
| Assets Current | $3.6M | $959.6K | $2.5M | $7.1M | $12.7M | $33.7M | $8.0M | $28.7M | $20.3M |
| Assets | $18.7M | $16.1M | $20.6M | $20.9M | $21.9M | $44.2M | $24.0M | $45.1M | $31.6M |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$92.3K | $89.2K | -$10.6K | $33.8K | -$2.0K | $53.3K | -$5.6K | -$1.5M | -$367.8K |
| Operating Lease Liability Current | $24.4K | $102.2K | $125.2K | $310.5K | $145.4K | $432.6K | $982.3K | ||
| Cash | $3.5M | $874.2K | $5.2M | $12.0M | $16.2M | ||||
| Accounts Payable And Accrued Liabilities Current | $1.1M | $918.6K | $1.9M | $6.2M | $4.2M | $3.2M | $2.6M | ||
| Prepaid Expense And Other Assets Current | $139.6K | $85.3K | $422.1K | $744.0K | $593.5K | $1.4M | $1.1M | ||
| Operating Lease Liability Noncurrent | $14.2K | $99.5K | $30.8K | $23.9K | $155.1K | ||||
| Gain Loss On Investments | -$1.0M | -$77.2K | -$520.8K | -$8.0M | $25.2M | -$81.8K | |||
| Intangible Assets Net Excluding Goodwill | $147.3K | $752.7K | $880.3K | $964.9K | $1.3M | $1.4M | $1.5M | ||
| Accounts Receivable Net Current | $47.7K | $174.4K | $78.7K | $62.2K | $40.5K | $2.8K | |||
| Property Plant And Equipment Net | $1.7M | $2.8M | $3.7M | $4.7M | $7.1M | $4.3M | $346.6K | ||
| Long Term Investments | $15.1M | $15.1M | $16.1M | $9.7M | |||||
| Operating Lease Right Of Use Asset | $182.1K | $347.0K | $154.4K | $547.4K | $959.6K | ||||
| Loss Gain On Investments In Marketable Securities Net | -$9.3K | -$134.1K | -$8.0M | $25.2M | -$81.8K | $501.5K | |||
| Additional Paid In Capital Common Stock | $97.0M | $93.5M | $93.0M | ||||||
| Payment Of Finance Lease Obligations | $49.4K | $53.8K | $53.8K | $53.8K | $58.3K | ||||
| Accretion Of Finance Lease Obligation | $1.4K | $4.5K | $7.3K | $10.0K | $7.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2017 |
|---|---|
| Stockholders Equity * | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | |
| Retained Earnings Accumulated Deficit | |
| Minority Interest | |
| Liabilities Current | |
| Liabilities And Stockholders Equity | |
| Liabilities | |
| Assets Current | |
| Assets | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | |
| Operating Lease Liability Current | |
| Cash | |
| Accounts Payable And Accrued Liabilities Current | |
| Prepaid Expense And Other Assets Current | |
| Operating Lease Liability Noncurrent | |
| Gain Loss On Investments | -$402.1K |
| Intangible Assets Net Excluding Goodwill | |
| Accounts Receivable Net Current | |
| Property Plant And Equipment Net | |
| Long Term Investments | |
| Operating Lease Right Of Use Asset | |
| Loss Gain On Investments In Marketable Securities Net | |
| Additional Paid In Capital Common Stock | |
| Payment Of Finance Lease Obligations | |
| Accretion Of Finance Lease Obligation |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.8M | -$1.2M | -$7.7M | -$12.3M | -$14.7M | -$15.9M | -$13.4M | -$10.0M |
| Net Cash Provided By Used In Investing Activities | $58.6K | $624.8K | $2.4M | $16.5M | $1.8M | -$108.1K | -$6.1M | |
| Net Cash Provided By Used In Financing Activities | $4.4M | $4.1M | $6.6M | $2.8M | $12.4M | -$7.3M | $25.5M | |
| Increase Decrease In Due To Related Parties | -$464.00 | $464.00 | -$8.5K | -$6.8K | -$264.9K | -$120.6K | -$26.1K | $1.0K |
| Increase Decrease In Accounts Receivable | -$41.3K | -$126.7K | $95.7K | $16.5K | $21.7K | $37.7K | $2.8K | |
| Payments To Acquire Property Plant And Equipment | $3.0K | $186.9K | $131.8K | $161.3K | $837.1K | $5.6M | ||
| Increase Decrease In Inventories | -$14.5K | -$8.1K | -$3.4K | $4.9K | $3.5K | $30.6K | ||
| Increase Decrease In Deposit Other Assets | -$29.1K | -$19.3K | -$20.00 | -$55.4K | $112.0K | |||
| Share Based Compensation | $1.3M | $1.6M | $1.7M | $1.5M | $1.6M | |||
| Depreciation Depletion And Amortization | $1.1M | $1.2M | $1.2M | $1.3M | $1.3M | $682.3K | ||
| Proceeds From Related Party Debt | $2.5M | $500.0K | $3.5M | $1.0M | $6.3M | |||
| Proceeds From Issuance Of Common Stock | $3.1M | $1.6M | $4.0M | $17.5M | $11.1M | |||
| Increase Decrease In Due From Related Parties | -$961.00 | -$63.1K | $46.3K | -$112.6K | -$168.1K | $79.2K | ||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$28.4K | -$422.7K | $398.6K | $1.9M | $986.2K | $58.6K | ||
| Increase Decrease In Operating Lease Liability | -$92.0K | -$120.8K | -$389.4K | -$369.5K | -$450.8K | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$17.5K | -$291.1K | -$227.5K | $29.9K | ||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $398.6K | $1.9M | $855.3K | $801.0K | $986.2K | $58.6K | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $93.2K | $20.1M | $952.2K | $999.1K | $2.3K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.19 | -$0.78 | -$0.62 | -$2.75 | -$7.15 | $2.00 | -$0.64 | -$0.53 |
| Weighted Average Number Of Diluted Shares Outstanding | 7.4M | 5.5M | 4.5M | 3.6M | 3.5M | 3.2M | 29.0M | 27.9M |
| Weighted Average Number Of Shares Outstanding Basic | 7.4M | 5.5M | 4.5M | 3.6M | 3.5M | 3.1M | 29.0M | 27.9M |
| Earnings Per Share Basic | $-0.19 | $-0.78 | $-0.62 | $-2.75 | $-7.15 | $2.03 | $-0.64 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Sundry Income | $564.00 | $36.8K | $48.0K | $146.3K | $365.9K | $232.5K | |||
| Stock Issued During Period Value Stock Options Exercised | $451.7K | $16.5K | $169.5K | $694.2K | $60.6K | ||||
| Interest Paid Net | $94.1K | $64.7K | $273.2K | $131.6K | $557.3K | $607.0K | |||
| Legal And Professional Fees | $2.9M | $2.6M | $2.9M | $3.4M | $1.8M | ||||
| Other Operating Income Expense Net | $170.8K | -$272.6K | -$1.1M | ||||||
| Operating Costs And Expenses | $1.8M | $3.9M | $11.2M | ||||||
| Other Expenses | $261.0K | $392.5K | $877.4K | $220.9K | $560.7K | ||||
| Increase Decrease Due From Other Related Parties | -$75.7K | -$84.0K | -$156.7K | -$502.0K | -$751.00 | ||||
| Healthcare Service Income | $1.3M | $1.5M | $911.5K | $535.2K | $383.5K | ||||
| Additional Paid In Capital | $93.0M | $45.3M | $43.5M | $38.2M | $24.9M | $23.0M | $5.3M | ||
| Exchange Difference On Translation Of Foreign Operation | -$44.4K | $35.8K | -$49.9K | $58.8K | -$10.9K | $5.3K | |||
| Due From Brokers | $652.00 | $76.4K | $160.3K | $317.0K | $819.0K | $179.5K | |||
| Stock Issued During Period Value New Issues | $1.6M | $4.0M | $16.8M | ||||||
| Interest Income | $235.6K | $41.2K | $825.00 | $79.6K | $108.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2017 |
|---|---|
| Sundry Income | |
| Stock Issued During Period Value Stock Options Exercised | |
| Interest Paid Net | |
| Legal And Professional Fees | $98.6K |
| Other Operating Income Expense Net | |
| Operating Costs And Expenses | |
| Other Expenses | |
| Increase Decrease Due From Other Related Parties | |
| Healthcare Service Income | |
| Additional Paid In Capital | |
| Exchange Difference On Translation Of Foreign Operation | |
| Due From Brokers | |
| Stock Issued During Period Value New Issues | |
| Interest Income |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.